Report copyright - Orally bioavailable glutamine antagonist prodrug JHU-083Technology®, clone 5A1E), followed by a secondary antibody conjugated to Cy3 diluted 1:500 (Jackson ImmunoResearch). DAPI was
Please pass captcha verification before submit form